Form 6K Ascentage Pharma Group Int Ltd For: 17 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ascentage Pharma Group Int Ltd (AAPG)
Ascentage Pharma Group Int Ltd stock price live, this page displays NASDAQ AAPG stock exchange data. View the AAPG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ascentage Pharma Group Int Ltd real time stock price chart below.
What Is the Ascentage Pharma Group Int Ltd Stock Price Today?
The Ascentage Pharma Group Int Ltd stock price today is 37.20.
What Is the Stock Symbol for Ascentage Pharma Group Int Ltd?
The stock symbol for Ascentage Pharma Group Int Ltd is ""AAPG.""
What Stock Exchange Does Ascentage Pharma Group Int Ltd Trade On?
Ascentage Pharma Group Int Ltd is listed and trades on the NASDAQ stock exchange.
Is Ascentage Pharma Group Int Ltd a Good Stock to Buy?
Determining whether Ascentage Pharma Group Int Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AAPG quote. (ISIN: US04390B1052)
What Is the Ascentage Pharma Group Int Ltd Stock Price Today?
The Ascentage Pharma Group Int Ltd stock price today is 37.20.
What Is the Stock Symbol for Ascentage Pharma Group Int Ltd?
The stock symbol for Ascentage Pharma Group Int Ltd is ""AAPG.""
What Stock Exchange Does Ascentage Pharma Group Int Ltd Trade On?
Ascentage Pharma Group Int Ltd is listed and trades on the NASDAQ stock exchange.
Is Ascentage Pharma Group Int Ltd a Good Stock to Buy?
Determining whether Ascentage Pharma Group Int Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AAPG quote. (ISIN: US04390B1052)
NASDAQ
Currency in USD
37.20
+0.20(+0.54%)
Closed·
After Hours
37.320.00(0.00%)
·
Fair Value
An estimate of a Ascentage Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.00
37.50
52 wk Range
16.50
43.58
AAPG Scorecard
Full Analysis
Analysts anticipate sales decline in the current year
AAPG is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Ascentage Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.0037.50
52 wk Range
16.5043.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AAPG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ascentage Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
28.00
Downside
-24.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- Form 6K Ascentage Pharma Group Int Ltd For: 8 July
- Investing.com
- Form 6K Ascentage Pharma Group Int Ltd For: 17 July
- Investing.com
- Form 6K Ascentage Pharma Group Int Ltd For: 10 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Ascentage Pharma Group Int Ltd Company Profile
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin’s lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and provision of science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.
Compare AAPG to Peers and Sector
Metrics to compare | AAPG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAAPGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −61.5x | −32.3x | −0.5x | |
PEG Ratio | −1.03 | 0.31 | 0.00 | |
Price/Book | 94.4x | 6.8x | 2.6x | |
Price / LTM Sales | 25.4x | 26.1x | 3.3x | |
Upside (Analyst Target) | −24.7% | −3.0% | 45.1% | |
Fair Value Upside | Unlock | −14.0% | 7.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 28.00
(-24.73% Downside)
Earnings
Latest Release
Apr 16, 2025
EPS / Forecast
-1.82 / --
Revenue / Forecast
156.90M / --
People Also Watch
FAQ
What Stock Exchange Does Ascentage Pharma Trade On?
Ascentage Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Ascentage Pharma?
The stock symbol for Ascentage Pharma is "AAPG."
What Is the Ascentage Pharma Market Cap?
As of today, Ascentage Pharma market cap is 3.41B.
What Is Ascentage Pharma's Earnings Per Share (TTM)?
The Ascentage Pharma EPS (TTM) is -1.34.
From a Technical Analysis Perspective, Is AAPG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Ascentage Pharma Stock Split?
Ascentage Pharma has split 0 times.
How Many Employees Does Ascentage Pharma Have?
Ascentage Pharma has 567 employees.
What is the current trading status of Ascentage Pharma (AAPG)?
As of 04 Aug 2025, Ascentage Pharma (AAPG) is trading at a price of 37.20, with a previous close of 37.20. The stock has fluctuated within a day range of 36.00 to 37.50, while its 52-week range spans from 16.50 to 43.58.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.